RECRUITING

Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection

Description

Prospective single-masked (study participant will be masked), randomized controlled trial to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthritis.

Conditions

Osteoarthritis of the Knee
Talk to us

Related Conditions:

Osteoarthritis of the Knee

Study Overview

On this page

Study Details

Study overview

Prospective single-masked (study participant will be masked), randomized controlled trial to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthritis.

Bone Marrow Aspirate Concentrate vs Corticosteroid Injection for Symptomatic Osteoarthritis (OA) of the Knee: A Randomized Controlled Trial

Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection

Condition
Osteoarthritis of the Knee
Intervention / Treatment

-

Contacts and Locations

Chicago

Rush University Medical Center, Chicago, Illinois, United States, 60612

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients between the ages of 18-70
  • * Long standing knee pain from osteoarthritis (KL grade 2-3) despite conventional treatments such as activity modification, weight loss, physical therapy, analgesics, nonsteroidal anti-inflammatory drugs, or injection therapy for at least 6 weeks
  • * 7-day average pain score of at least 4 on VAS scale
  • * Systemic diseases (Diabetes, malignancies, infections, etc.)
  • * Post-traumatic arthritis
  • * Patient had intra-articular injection on affected knee in last three months

Ages Eligible for Study

18 Years to 70 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Rush University Medical Center,

Jorge Chahla, MD, PRINCIPAL_INVESTIGATOR, Rush University Medical Center Associate Professor and Surgeon

Study Record Dates

2027-03-31